Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Global High Content Screening Market (2022 to 2027) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts

Published

on

Dublin, April 08, 2022 (GLOBE NEWSWIRE) — The “High Content Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

The global high content screening market reached a value of US$ 1.1 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 1.8 Billion by 2027, exhibiting at a CAGR of 8.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

High content screening (HCS), or high content analysis, refers to an analytical method of automated microscopy that uses visualization tools to obtain quantitative data from cell populations. It is an integration of modern cell biology, flow cytometry and robotic handling that involves fluorescence imaging for analyzing various biochemical and physical characteristics of the sample cells. This aids in drug discovery, complex multivariate drug profiling and toxicity studies, while utilizing robots, detectors and software to monitor the entire process.

The increasing prevalence of neurodegenerative diseases across the globe, such as Alzheimer’s and Parkinson’s, is one of the key factors driving the market growth. The rising need for cost-effective drug discovery systems in the pharmaceutical industry is also providing a boost to the market growth. In comparison to the traditionally used methods, HCS solutions prove to be inexpensive and resource- and time-efficient for analyzing the potential toxicity of chemicals and complex substances.

Advancements in informatics solutions and imaging instruments are acting as another growth-inducing factor. HCS equipment manufacturers are producing innovative equipment that is integrated with software platforms and artificial intelligence (AI) systems to enhance the visualization capabilities of the devices. In line with this, the development of automated systems for analyzing cell separation and scalability has further enhanced the adoption of HCS technology. Other factors, including the rising geriatric population and increasing investments in the research and development (R&D) of advanced screening systems, are projected to drive the market further.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global high content screening market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end-user.

Breakup by Product:

  • Instruments
  • Cell Imaging and Analysis Systems
  • Flow Cytometers
  • Consumables
  • Reagents & Assay Kits
  • Microplates
  • Other Consumables
  • Software
  • Services
  • Accessories

Breakup by Application:

  • Target Identification and Validation
  • Primary Screening and Secondary Screening
  • Toxicity Studies
  • Compound Profiling
  • Other Applications

Breakup by End-User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Government Institutes
  • Contract Research Organizations (CROs)

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Biotek Instruments Inc., Danaher Corporation, GE Healthcare, Merck Millipore, Perkinelmer Inc., Tecan Group Ltd., Thermo Fisher Scientific, Yokogawa Electric Corporation, etc.

Key Questions Answered in This Report:

  • How has the global high content screening market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global high content screening market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global high content screening market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global High Content Screening Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product
6.1 Instruments
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Cell Imaging and Analysis Systems
6.1.2.2 Flow Cytometers
6.1.3 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Major Types
6.2.2.1 Reagents & Assay Kits
6.2.2.2 Microplates
6.2.2.3 Others
6.2.3 Market Forecast
6.3 Software
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Services
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Accessories
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Application
7.1 Target Identification and Validation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Primary Screening and Secondary Screening
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Toxicity Studies
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Compound Profiling
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by End-User
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Academic and Government Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Contract Research Organizations (CROs)
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Indicators

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Becton, Dickinson and Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Bio-Rad Laboratories Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Biotek Instruments Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Danaher Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 GE Healthcare
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck Millipore
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Perkinelmer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Tecan Group Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Thermo Fisher Scientific
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Yokogawa Electric Corporation
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/5abmg7

Attachment


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Kharon Data and Technology Selected by U.S. Department of the Treasury

Published

on

kharon-data-and-technology-selected-by-us.-department-of-the-treasury

Treasury officers will gain access to Kharon’s platform for sanctions-related risk intelligence
WASHINGTON, May 7, 2024 /PRNewswire/ — Kharon announces the signing of a contract with the U.S. Department of the Treasury. Through this engagement, officials within the Treasury Department will gain access to Kharon’s global risk analytics platform. Kharon’s insights and analytic tools are used by leading financial institutions, companies, and governments to address global security threats, and to support risk management in connection with KYC, transaction screening, sanctions evasion, investigations, and trade controls.

This award underscores Kharon’s commitment to helping organizations navigate the complexities of sanctions compliance and combatting sanctions evasion, including the OFAC and EU 50 percent rules, FinCEN alerts on Harmonized System (HS) codes and export control evasion, and countering terrorist financing.
Alongside a recent award with the U.S. Customs and Border Protection, this engagement with the Treasury Department expands the U.S. Government’s access to Kharon insights, data analytics, and investigative workflow tools for critical public sector security objectives.
Kharon’s expertise in generating data-driven insights will assist the Treasury Department with its mission of disrupting the financial operations that underpin the networks of foreign actors tied to global security threats, including terrorism, nuclear and missile proliferation, Russia’s invasion of Ukraine, human rights violators, transnational crime, corruption, and others. Kharon insights draw upon all available open-source information and are powered by world-class subject matter expertise and data analytics combined with cutting-edge AI and natural language processing (NLP) systems. Kharon has been awarded multiple patents for its transformative analytic and workflow tools that have helped leading banks and corporates minimize risk and maximize efficiency for critical compliance, investigative, and risk management functions.
“Effectively implementing sanctions and trade controls requires both public and private sector organizations to have the insights needed to counter evasion,” said Howard Mendelsohn, Kharon’s Chief Client Officer. “This award represents an additional step in aligning critical insights across the public and private sectors. We are proud to support the U.S. Department of the Treasury in its critical mission.”
About Kharon
Kharon helps leading organizations identify a wide range of sanctions and compliance risks, critical to managing financial crimes, supply chain exposure, export controls, investment risk, and more. Combining cutting-edge technology and data science with industry-leading research, our solutions provide the critical insights required for a comprehensive view of illicit finance and other commercial threats.
The Kharon leadership team includes former senior officials from the U.S. Government who have leveraged their unique expertise to build risk management solutions that are trusted by the world’s top financial institutions, global corporates, and professional services firms.
Visit Kharon.com and follow Kharon on LinkedIn to learn more.
Media Contacts [email protected]
Logo – https://mma.prnewswire.com/media/1283302/Kharon_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/kharon-data-and-technology-selected-by-us-department-of-the-treasury-302137445.html

Continue Reading

Artificial Intelligence

Imaging Endpoints Unveils New Initiative with Revolution Endpoints™, an Investment Subsidiary to Accelerate Innovation and Growth

Published

on

imaging-endpoints-unveils-new-initiative-with-revolution-endpoints™,-an-investment-subsidiary-to-accelerate-innovation-and-growth

SCOTTSDALE, Ariz., May 7, 2024 /PRNewswire/ — Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution Endpoints, focused on leveraging the Company’s strong leadership and financial position to acquire synergistic technologies and services. This initiative aims to further advance the company’s internal research programs targeted toward development of cutting-edge service offerings.

Revolution Endpoints is already meticulously evaluating emerging technologies for adoption while exploring licensing, partnership, or acquisition of the most promising and synergetic opportunities. By identifying and integrating emerging technologies that complement internal development efforts and existing services, Imaging Endpoints intends to ensure it continues to lead the industry in service offerings.
Doug Dean Burkett, CEO and President of Imaging Endpoints commented: “For fifteen years we have been relentlessly executing on a consistent, unwavering strategy to organically grow our leadership in oncology-focused imaging CRO services. We are now generally recognized as leading the industry in science and quality, and our efforts have yielded remarkable growth.  We are fortunate to be in a position to invest in emerging technologies that are synergistic with our own development projects and our vision to Connect Imaging to the Cure™. Through this new subsidiary, we are excited to explore new frontiers, support transformative ideas, and continue our mission of advancing healthcare and improving patient outcomes.”
IE believes in the power of collaboration and innovation to drive progress in the fight against cancer. Revolution Endpoints is engaging with emerging technology leaders within AI assisted image evaluation, quantitative biomarkers, big datasets, predictive analytics and NLP, 3D imaging, AR, VR, AI enhanced enterprise automation, and blockchain technology that have potential to further streamline and improve both image workflows and efficacy analysis. Service providers with synergistic technologies and service offerings may also be of interest.
For more information about Revolution Endpoints or to discuss your emerging technology with our experts, please visit Revolution Endpoints or contact us at [email protected]
About Imaging Endpoints
Imaging Endpoints (IE) is passionately focused on its vision to Connect Imaging to the Cure. With a flawless global inspection record and a 95% marketing authorization success rate, IE has a proven track record of supporting successful regulatory submissions across the globe. IE’s commitment to quality, innovation, and excellence has positioned it as the global leader in oncology imaging.
Imaging Endpoints is the largest oncology-focused Imaging CRO, with 8 offices strategically located across 6 countries including Scottsdale, AZ, Cambridge, MA; London, UK; Leiden, Netherlands; Basel, Switzerland; Hyderabad, India; and Shanghai, China.
IE is an affiliate of HonorHealth, one of the largest healthcare systems nationally, and also an affiliate of Southwest Medical Imaging, Ltd. (SMIL/RadPartners), part of the largest private radiology group in the U.S.
Media Contact
Contact No: 480.314.3070
Photo: https://mma.prnewswire.com/media/2405411/Imaging_Endpoints_Revolution.jpgLogo: https://mma.prnewswire.com/media/2405461/Imaging_Endpoints_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/imaging-endpoints-unveils-new-initiative-with-revolution-endpoints-an-investment-subsidiary-to-accelerate-innovation-and-growth-302138084.html

Continue Reading

Artificial Intelligence

ICIS Launches Ask ICIS Generative AI Commodities Assistant

Published

on

icis-launches-ask-icis-generative-ai-commodities-assistant

Global commodities intelligence provider launches generative AI assistant to boost access to expert insights and data around the global energy and chemicals markets
LONDON, May 7, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, announced the launch of Ask ICIS, a first of its kind generative AI assistant that will enhance access to ICIS’ standout intelligence and insights for the energy and chemicals markets.

 
As commodity markets become more complex and dynamic, the need for both highly accurate and up-to-the-minute information has never been more important. Underpinned by unparalleled chemical and energy market datasets and decades of editorial expertise, Ask ICIS combines ICIS’ vast market intelligence with the power of generative AI technology.
Currently in beta, Ask ICIS is available in multiple languages and supported with citations, Ask ICIS allows customers to delve deeper, supporting timely, confident strategic decision-making with comprehensive market intelligence. 
“At ICIS, we are committed to delivering the best possible intelligence to our customers so that they can arrive at the best possible outcomes for the decisions they need to make,” said Jeff Skelton, CEO of ICIS. “Through Ask ICIS, we are taking our ambition one step further by unlocking access to our trusted and actionable insights to provide immediate and personalized responses to complex customer enquiries  in a fraction of the time. We are committed to helping our customers adopt and scale new technologies, enabling them to make better decisions and bring the maximum value possible to their organizations.”
Sourced exclusively from ICIS’ expert data and insight, Ask ICIS connects users to content tailored directly to their needs based on their role, region, and priorities. Source citations are built into every response allowing users to delve deeper and enabling more confident, timely, strategic decision-making. In addition, Ask ICIS also provides bespoke suggested prompts and follow-up questions to allow users to uncover additional insights and “unknown unknowns” to gain an unprecedented view and understanding of market events.
“To drive success in today’s commodity markets you need to have the most innovative tools and information at your disposal,” said Skelton. “We strongly believe that Ask ICIS not only helps our customers achieve new goals and levels of performance but has also sets a new bar for the way commodity markets can now access intelligence.”
For more information on ICIS please visit, www.icis.com. For more information on Ask ICIS, or if you are an ICIS customer  interested in joining the beta progam, please visit: https://www.icis.com/explore/contact/ask-icis/.
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of $78.2bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £62.4bn | €73bn | $78.2bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-launches-ask-icis-generative-ai-commodities-assistant-302135677.html

Continue Reading

Trending